Papers
8
Total Citations
124
H-Index
7
About
Jung Kwon Kim is a leading urologic oncologist whose research centers on optimizing surgical and therapeutic strategies for prostate and renal cancers. His work has fundamentally advanced the understanding of how to manage complex renal tumors, particularly through the comparison of robotic and open partial nephrectomy. In a landmark 2019 study (43 citations), he demonstrated that robotic partial nephrectomy offers comparable oncologic outcomes to open surgery for highly complex tumors (RENAL score ≥10), challenging traditional surgical paradigms. Kim has also pioneered the use of personalized medicine in urology, developing a three-dimensional printed transparent kidney model that serves as a surgical navigator for complex partial nephrectomies (16 citations). His contributions to prostate cancer care are equally significant, including a randomized controlled trial showing that a novel biofeedback device (Anykegel) improves urinary incontinence recovery after robotic prostatectomy (25 citations), and a critical analysis of Gleason score upgrading that helps identify candidates for active surveillance (17 citations). More recently, Kim has explored the microbiome’s role in prostate cancer and compared functional outcomes between robotic prostatectomy and high-intensity focused ultrasound, demonstrating his commitment to refining treatment selection. With over 120 total citations, his work directly shapes clinical decision-making in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8